Comparative efficacy of combination immunotherapy and targeted therapy in the treatment of BRAF-mutant advanced melanoma: a matching-adjusted indirect comparison

Atkins, MB; Tarhini, A; Rael, M; Gupte-Singh, K; O'Brien, E; Ritchings, C; Rao, S; McDermott, DF

Atkins, MB (reprint author), Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.

IMMUNOTHERAPY, 2019; 11 (7): 617

Abstract

Aim: Comparison of clinical outcomes of nivolumab + ipilimumab versus BRAF + MEK inhibitors (dabrafenib + trametinib or vemurafenib + cobimetinib) in ......

Full Text Link